{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:57:30Z","timestamp":1781049450592,"version":"3.54.1"},"reference-count":0,"publisher":"Pasifika Medical Association Group","issue":"1636","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NZMJ"],"abstract":"<jats:p>aim: Our aim was to determine the 30- and 90-day all-cause mortality of healthcare-associated Staphylococcus aureus bacteraemia\n(HA-SAB) and determine mortality risk factors.\nmethod: We collected HA-SAB events from 1 July 2022 to 30 June 2024. Patient age, sex, ethnicity and source of HA-SAB were submitted\nvia a secure portal. Patients\u2019 National Health Index numbers were matched to the National Minimum Dataset, and 30- and 90-day allcause\nmortality was determined. The mortality rate was calculated as a percentage of all HA-SAB events and by age, sex, ethnicity and\nsource.\nresults: There were 961 HA-SAB events: a rate of 0.15 cases per 1,000 inpatient bed days. Thirty- and 90-day all-cause mortality were\n13.8% and 20.7%, respectively. There was no difference in mortality by sex or ethnicity. Mortality increased with age and increased\nsignificantly for \u226575 years of age. Invasive medical devices were the source of 70% of HA-SAB events, organs were the source of 12% of\nHA-SAB events, and surgical site infections were the source of 8% of HA-SAB events.\nconclusion: The 30- and 90-day all-cause mortality associated with HA-SAB is high. The most common sources are vascular access\ndevices. The use of a \u201ccare bundle\u201d incorporating proven interventions, applied using a quality improvement framework, should\nreduce patient harm from these events.<\/jats:p>","DOI":"10.26635\/6965.7321","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:05:51Z","timestamp":1781046351000},"page":"52-59","source":"Crossref","is-referenced-by-count":0,"title":["Mortality associated with healthcareassociated Staphylococcus aureus bacteraemia in Aotearoa New Zealand"],"prefix":"10.26635","volume":"139","author":[{"given":"Sally","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Grae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11177","published-online":{"date-parts":[[2026,6,12]]},"container-title":["New Zealand Medical Journal"],"original-title":[],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:05:53Z","timestamp":1781046353000},"score":1,"resource":{"primary":{"URL":"https:\/\/nzmj.org.nz\/journal\/vol-139-no-1636\/mortality-associated-with-healthcare-associated-staphylococcus-aureus-bacteraemia-in-aotearoa-new-zealand"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":0,"journal-issue":{"issue":"1636","published-online":{"date-parts":[[2026,6,12]]}},"URL":"https:\/\/doi.org\/10.26635\/6965.7321","relation":{},"ISSN":["1175-8716"],"issn-type":[{"value":"1175-8716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}